Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: a Randomized, Placebo-controlled Pilot Trial

NCT06091332 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT06091332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06091332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: a Randomized, Placebo-controlled Pilot Trial
Lead sponsor
Huashan Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
January 5, 2024
Completion date
December 31, 2026
Enrollment
75 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brainstem stroke, cavernous malformations, intracerebral hemorrhage